title: CD25 saturation rate in heart transplant patients receiving two-dose daclizumab induction.
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Potter
authors.forename: Nadia
authors.initials: N
authors.lastname: Giannetti
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Routy
authors.forename: Renzo
authors.initials: R
authors.lastname: Cecere
authors.forename: Marcelo
authors.initials: M
authors.lastname: Cantarovich
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000077561:Daclizumab; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D000077561:Daclizumab